Always clean the injection site before injecting the medication to reduce the risk of injection site infections
While renal benefits of these medications have centered on diabetic populations, 2,3 limited data exist on kidney function changes in non-diabetic patients using GLP-1s
Generally, nausea should improve after a few weeks once your body has had a chance to adjust to the medication or the higher dose, Cardel says
Steady Delivery: A transdermal patch could deliver the medication slowly and continuously over time, which might potentially reduce the intensity of side effects like nausea that can occur with a weekly bolus injection
Ally Hirschlag Tester Ally Hirschlag is an award-winning journalist with over 10 years of experience editing and writing health, fitness, beauty, lifestyle, and science content
doi:10.1016/S0140-6736(23)01053-X PubMed: This trial evaluated retatrutide in 281 participants with type 2 diabetes, showing up to 16.94% weight loss and significant HbA1c reductions with favorable safety profile comparable to other GLP-1 based therapies
